...
首页> 外文期刊>The Journal of heart valve disease >Tricuspid valve biopsy: a potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves.
【24h】

Tricuspid valve biopsy: a potential source of cardiac myofibroblast cells for tissue-engineered cardiac valves.

机译:三尖瓣活检:用于组织工程性心脏瓣膜的心肌成纤维细胞的潜在来源。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIMS OF THE STUDY: As progress is made in the development of a tissue-engineered cardiac valve, the need for a reliable cell source is particularly important. A technique has been developed for the reliable biopsy of tricuspid valve leaflets. Expanding the harvested cells in culture is feasible and provides a source of leaflet cells that are structurally and functionally similar to the pulmonary and aortic valve leaflet cells that they may replace. METHODS: Thirteen sheep underwent tricuspid valve biopsy. Transthoracic echocardiography (TTE) was performed to evaluate function and guide the subsequent biopsy. Myofibroblasts were isolated from the biopsy samples, expanded in culture through 10 passages, and evaluated with immunocytochemistry for valve cell markers. Two animals were sacrificed acutely, two animals died during the immediate postoperative period, and nine animals survived for four weeks or more. RESULTS: All preoperative and pre-explantation echocardiograms were normal. Both animals sacrificed acutely showed that the tricuspid valve leaflet was indeed biopsied with this technique. Two perioperative deaths occurred; one animal died secondary to injury of the chorda tendinea with subsequent destruction of the posterior leaflet; another died from disruption of the superior vena cava that led to irreversible cardiac tamponade. At sacrifice (2 to 17 weeks), all other animals showed intact tricuspid valves with normal leaflet anatomy. All cultured biopsies generated myofibroblasts that were immunocytochemically positive for alpha smooth muscle actin, chondroitin sulfate, vimentin and fibronectin. CONCLUSION: Biopsy of the tricuspid valve to obtain recipient cardiac valve leaflet cells is possible, and the technique is simple and reliable. Biopsy of the leaflet does not compromise function. Interstitial cells can be harvested and expanded in culture. Cellular structure and function is preserved and is similar to that of other cardiac leaflet cells. Tricuspid valve leaflet biopsies are apotential source for harvesting cells to be used in the development of a tissue-engineered cardiac valve.
机译:研究的背景和目的:随着组织工程化心脏瓣膜的开发取得进展,对可靠细胞源的需求尤为重要。已经开发了用于三尖瓣小叶的可靠活检的技术。在培养物中扩增收获的细胞是可行的,并提供了小叶细胞的来源,这些小叶细胞的结构和功能与它们可以替代的肺和主动脉瓣小叶细胞相似。方法:对13只绵羊进行了三尖瓣活检。经胸超声心动图检查(TTE)以评估功能并指导随后的活检。从活检样品中分离出成肌纤维细胞,将其培养扩增10代,并用免疫细胞化学评估了瓣膜细胞标记物。急性处死两只动物,在术后立即死亡两只动物,九只动物存活四个星期或更长时间。结果:所有术前和植入前超声心动图均正常。急性处死的两只动物都表明,确实用这种技术对三尖瓣小叶进行了活检。发生了两次围手术期死亡;一只动物死于肌腱损伤,随后破坏了后叶;另一人死于上腔静脉破裂,导致不可逆的心脏压塞。处死(2至17周)时,所有其他动物显示完整的三尖瓣,小叶解剖正常。所有培养的活检组织均生成肌成纤维细胞,其对α平滑肌肌动蛋白,硫酸软骨素,波形蛋白和纤连蛋白免疫细胞化学阳性。结论:可以对三尖瓣进行活检以获取受体心脏瓣膜小叶细胞,该技术简单可靠。活检不影响功能。间质细胞可以收获并在培养中扩增。细胞结构和功能得以保留,与其他心脏小叶细胞相似。三尖瓣小叶活检是收集用于组织工程性心脏瓣膜的细胞的潜在来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号